◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › 0-9 › 0767

Zhong Ji Longevity Science Group Limited (0767) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Diagnostics & Research · DATA UPDATED 2026-10-06

Zhong Ji Longevity Science Group Limited (0767) operates in the Diagnostics & Research industry and is headquartered in Kowloon, Hong Kong with about 31 employees. Its market capitalization is roughly HK$306 million. In the fiscal year ended 2025-12-31, 0767 reported HK$162M in revenue and (HK$17M) in net income.

Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China. It operates through Longevity Science Business; Money Lending and Financial Advisory Business; Securities and Other Investments; and Property Investment segments.

Interactive charts & full statements → Open the 0767 valuation workbench →

0767 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueHK$162MHK$166MHK$65MHK$90M—
Gross ProfitHK$26MHK$57MHK$56MHK$84M—
Operating Income (EBIT)(HK$24M)(HK$9M)(HK$25M)HK$12M—
Net Income(HK$17M)(HK$35M)HK$2M(HK$1M)—

HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

0767 Free Cash Flow History

0767 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsHK$500MHK$526MHK$509MHK$485M—
Total LiabilitiesHK$75MHK$126MHK$79MHK$64M—

HKD; HK$M / HK$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 0767 viewer.

Other Companies in Diagnostics & Research

← 0765All “0-9” companies0769 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.